1. Home
  2. NEON vs NEUP Comparison

NEON vs NEUP Comparison

Compare NEON & NEUP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neonode Inc.

NEON

Neonode Inc.

HOLD

Current Price

$1.40

Market Cap

27.9M

Sector

Technology

ML Signal

HOLD

NEUP

Neuphoria Therapeutics Inc.

HOLD

Current Price

$4.65

Market Cap

23.8M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
NEON
NEUP
Founded
1997
1996
Country
Sweden
United States
Employees
N/A
8
Industry
Industrial Machinery/Components
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
27.9M
23.8M
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
NEON
NEUP
Price
$1.40
$4.65
Analyst Decision
Hold
Strong Buy
Analyst Count
1
2
Target Price
$6.00
$21.00
AVG Volume (30 Days)
99.6K
52.1K
Earning Date
05-13-2026
05-23-2026
Dividend Yield
N/A
N/A
EPS Growth
37.88
N/A
EPS
N/A
N/A
Revenue
$3,108,000.00
N/A
Revenue This Year
$72.74
N/A
Revenue Next Year
$28.94
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.27
$3.65
52 Week High
$29.90
$21.31

Technical Indicators

Market Signals
Indicator
NEON
NEUP
Relative Strength Index (RSI) 43.34 61.85
Support Level $1.27 $3.91
Resistance Level $2.04 $5.06
Average True Range (ATR) 0.07 0.25
MACD 0.02 0.05
Stochastic Oscillator 54.90 100.00

Price Performance

Historical Comparison
NEON
NEUP

About NEON Neonode Inc.

Neonode Inc provides optical sensing solutions for contactless touch, and gesture sensing and also provides software solutions for machine perception that feature machine learning algorithms to detect and track persons and objects in video streams from cameras and other types of imagers. It markets and sells its solutions to customers in many different markets and segments including, office equipment, automotive, industrial automation, medical, military, and avionics. The company geographically operates in the United States, Japan, South Korea, Germany, Sweden, China, and other regions. A majority of its revenue is generated from Japan.

About NEUP Neuphoria Therapeutics Inc.

Neuphoria Therapeutics Inc is a clinical-stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. The company is advancing its drug candidate, BNC 210, an oral, proprietary, selective negative allosteric modulator of the Alpha7 nicotinic acetylcholine receptor, for the acute treatment of social anxiety disorder and for chronic treatment of post-traumatic stress disorder. The Company operates through a single operating and reportable segment focused on the discovery and development of allosteric ion channel modulators designed to transform the lives of patients suffering from serious central nervous system (CNS) disorders with high unmet medical need.

Share on Social Networks: